News

The Impact Journals news page hosts content about important news articles and press releases from our Journals and Editorial Board Members.

News

Mission
The Impact Journals news page hosts articles about important news stories from our journals and within the scientific community. Visit this page for the latest in medical advances, pharmaceutical progress, conference reports, and more.

Targeting FSP1 Regulates Iron Homeostasis in Drug-tolerant Persister Head and Neck Cancer Cells

Aging

January 24, 2024
PRESS RELEASE: A new research paper was published in Aging's Volume 16, Issue 1, entitled, “Targeting of FSP1 regulates iron homeostasis in drug-tolerant persister head and neck cancer cells via lipid-metabolism-driven ferroptosis.” continue reading »

Case Report: Lazarus Effect in a Patient Treated With Osimertinib for NSCLC With Leptomeningeal Disease

News

January 24, 2024
PRESS RELEASE: On January 16, 2024, a new case report was published in Oncotarget, entitled, “Lazarus effect in a patient initially empirically treated with osimertinib for EGFR L858R mutant non-small cell lung cancer with leptomeningeal disease: a case report.” continue reading »

Systematic Analysis of the Prognostic Value and Immunological Function of LTBR in Cancer

Aging

January 23, 2024
PRESS RELEASE: A new research paper was published in Aging’s Volume 16, Issue 1, entitled, “Systematic analysis of the prognostic value and immunological function of LTBR in human cancer.” continue reading »

Bone Marrow Adipocytes Provide Early Sign of Progression from MGUS to Multiple Myeloma

News

January 22, 2024
PRESS RELEASE: On January 16, 2024, a new research perspective was published in Oncotarget, entitled, “Bone marrow adipocytes provide early sign for progression from MGUS to multiple myeloma.” continue reading »

Dr. Blagosklonny’s Battle With Cancer (Part 1)

News

January 22, 2024
PRESS RELEASE: On January 3, 2024, Mikhail V. Blagosklonny M.D., Ph.D., published a new brief report in Oncoscience (Volume 11), entitled, “My battle with cancer. Part 1.” continue reading »